Cases 1 - 10 of 14
AstraZeneca AB et al v. Laurus Labs Limited et al
as 1:2024cv00459
Plaintiff:
AstraZeneca AB and AstraZeneca Pharmaceuticals LP
Defendant:
Laurus Labs Limited and Laurus Generics Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Merck Sharp & Dohme LLC v. Laurus Labs Limited et al
as 1:2022cv01348
Plaintiff:
Merck Sharp & Dohme LLC
Defendant:
Laurus Labs Limited and Laurus Generics Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Laurus Labs Ltd. et al
as 1:2022cv00220
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Laurus Labs Ltd. and Laurus Generics Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Laurus Labs Limited et al
as 1:2022cv00186
Plaintiff:
Novartis Pharmaceuticals Corporation
Counter Claimant:
Laurus Labs Limited and Laurus Generics Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2021cv01330
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alkem Laboratories Ltd., Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Laurus Labs Limited et al
as 1:2021cv01173
Plaintiff:
Merck Sharp & Dohme Corp.
Defendant:
Laurus Labs Limited and Laurus Generics Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2019cv01979
Defendant:
Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA Inc., Lupin Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Laurus Labs Ltd. et al
as 1:2019cv01596
Defendant:
Laurus Labs Ltd. and Laurus Generics Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
